Nearly a decade after the world’s attention was gripped by the Zika virus outbreak in Brazil, the disease is quiet...
HPV and PCV are the leading vaccines in the self-paid market in China. According to the WHO vaccine market report 2024, ...
The vaccine landscape in Asia-Pacific is undergoing significant transformation and growth. While public-sector programme...
Australia-based CSL Seqirus and Vaccine Industrial Company have signed a Memorandum of Understanding with the Ministry o...
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as Nor...
France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...
GC Biopharma, a South Korean biopharmaceutical company, has signed an agreement with Curevo Vaccine to secure contract m...
Professor Shawn Chen Xiaoyuan, Nasrat Muzayyin Professor in Medicine and Technology from the Department of Dia...
The Zambia National Public Health Institute (ZNPHI) and South Korea-based International Vaccine Institute (IVI) has sign...
Josephine Cheng, Senior Modality Leader, Process Solutions, Life Science Business of Merck The global pharmaceutic...
Australian children will now have stronger protection against pneumococcal with the Australian Government implementing a...
Australia-based Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for need...
Australian biotech firm CSL has announced its intention for CSL Seqirus to be demerged as a substantial ASX-listed entit...
The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca’s BEYFORTUS (nirsevimab) for the preventio...
Two leading scientific organisations based in Korea, the Korea Disease Control and Prevention Agency (KDCA) and Int...
Scientists have launched the first-ever library of adjuvants - substances that could boost the performance of vaccines t...
South Korea-based Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXV...
The Bhutan-International Vaccine Institute (IVI) Collaborating Centre has been officially launched in Thimphu, Bhutan, m...
